DEBRA BORCHARDT

Cannabis Providers Ready to Go as New Jersey OKs Recreational Marijuana Use – RealMoney

Now that New Jersey has voted in favor of the legalization of adult-use cannabis, investors want to know who the winners will be among cannabis providers. Voters in the state approved New Jersey Public Question 1, Marijuana Legalization Amendment (2020), which legalizes the recreational use of non-hemp cannabis for persons age 21 and over. It also permits possession, cultivation and sales of retail non-hemp cannabis. The constitutional amendment is set to take effect on Jan. 21, 2021. Patrik Jonsson, regional president of the Northeast for Curaleaf Holdings (CURLF) , said the transition to adult-use in New Jersey will take some […]

Share

REIT Market Fired Up for Cannabis – RealMoney – RealMoney

The market for cannabis REITs is heating up. Innovative Industrial Properties or IIP  (IIPR)  was the first to stake its claim in the market and continues to be an industry leader. It’s success in the space has spawned a new group of REITs that are hoping to have the same winning strategy. One of the main reasons REITs have proven to work in the cannabis industry is that banks don’t want to lend money to a cannabis company when it is looking for a building. Whether its brick and mortar retail or an industrial building for cultivation, banks continue to […]

Share

New York Lays the Groundwork for Legalizing Cannabis – RealMoney

Several key people in key positions in the State of New York have signaled an increasing openness to the idea of legalizing adult use cannabis. The item has appeared on the state budget but for various reasons but never got beyond that status. Now as the pandemic has wrecked the state’s economy, it’s looking more and more like a reality. “It was being considered even prior to the pandemic but now more than ever, as we’re finding how cash strapped our state will be as we run out of revenues, I think it will absolutely be on the table for […]

Share

One Way or Another, Cannabis Is on the Election Ballot – RealMoney

As the election quickly approaches, cannabis investors are keenly aware of the landscape and how it could play out for the industry. Looking at the Democratic party platform, candidates former Vice President Joe Biden and Senator Kamala Harris have taken the position of decriminalization and rescheduling, from DEA Schedule I, through executive action on the federal level. They have said that they support legalization of medical marijuana nationwide and believe states should be able to make their own decisions about recreational use. In addition to that, their approach is a combination of the previously proposed legislation known as the STATES […]

Share

Investing in Cannabis? Don't 'Write Off' This Item – RealMoney

Cannabis-deal tracking company Viridian Capital Advisors believes that more publicly traded cannabis companies will be taking big write-offs. Often for cannabis companies these include dropping the value on inventory or destroying the inventory altogether. It can even include unpaid accounts receivables or loans. The largest write-offs by cannabis companies are as follows: Aurora Cannabis (ACB) : $1.8 billion, per fiscal fourth quarter Canopy Growth (CGC) : $545 million, per fiscal fourth quarter TILT Holdings  (TLLTF) : $500 million, per 2018 annual report Tilray (TLRY) : $112 million, per the 2019 annual report Aurora wins the prize, as it recently warned investors that […]

Share

Is Psilocybin the New CBD? – RealMoney – RealMoney

Is psilocybin to psychedelic medicine what CBD is to medical marijuana? Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) and psilocin are chemical compounds that come from certain types of dried or fresh hallucinogenic mushrooms found in various parts of the world. There are over 180 different species of mushrooms that contain psilocybin. As psychedelic medicines begin to become decriminalized, psilocybin seems to be leading the way in this category, which also typically includes Ketamine, MDMA and LSD. Ketamine is an anesthetic that has been approved for use in drug-resistant depression patients. It is classified as a Schedule 3 drug. MDMA is a Schedule 1 drug […]

Share

Vape Recovery Goes Up in Smoke Amid Pandemic – RealMoney

Covid-19 could cause vape sales to hit the brakes on the product’s road to recovery following last year’s health crisis. Doesn’t it seem like a more innocent time, when the cannabis industry was worrying about e-cigarette vaping lung injury? Illicit makers of vape cartridges had been cutting vitamin E acetate into the cannabis oil with the tragic side effect that some consumers died. By February, 2,807 people had been hospitalized for the lung injuries and 68 people died. A result was that an emerging powerhouse of a cannabis category, vaping, was plunged into the abyss of uncertainty. However, as more was learned […]

Share